Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves first medication for obstructive sleep apnea, which also promotes weight loss
The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to severe OSA in people with obesity.
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
FDA approves Zepbound as a treatment for obstructive sleep apnea
Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and Drug Administration has appro
Weight Loss Drug Tirzepatide Now Approved for Sleep Apnea in Adults With Obesity
The approval was based on the results of the SURMOUNT-OSA trial, which found patients had fewer breathing disruptions.
FDA approves Zepbound for obstructive sleep apnea
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep apnea.
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025
In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known as Tirzepatide, for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
5d
on MSN
The First Sleep Apnea Drug Is Here
In the trial that Lilly, the drug's manufacturer, submitted in April to the FDA, scientists reported that the drug helped ...
The Spokesman-Review
17h
FDA approves weight-loss drug Zepbound to treat sleep apnea
Obstructive
sleep
apnea
occurs when a person’s upper airway becomes blocked ... The FDA first approved Zepbound to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'Baby Driver' actor dies
Man dies after saving family
Corrections officer dies
Christmas Eve attack arrest
Body found in wheel well
Escaped murderer captured
HEARTS Act signed into law
Pakistani airstrikes on AFG
Former Eagles LB dies at 79
Vows more weapons to UKR
Official national bird of US
Taxi hits pedestrians in NYC
Ambassador to Panama
Taiwan blocks $950M deal
Suriname ex-president dies
Kazakhstan plane crash
Hit by cyberattack
ISR strike kills journalists
Bird flu at Wash. sanctuary
Pet food recalled
Music producer Perry dies
Calls for peace in Ukraine
Russia arrests four suspects
Eye drops recalled
Sudan famine spreading
NC man charged w/ murder
Iran restores access
Discharged from hospital
Nolan’s next film revealed
To honor 3 NFL assistants
Related topics
Zepbound
Food and Drug Administration
Feedback